Fact CheckerSign in

NCT07293273Completed

Procedural Sedation in Renal Sympathetic Denervation

Impact of Dexmedetomidine and Fentanyl-Propofol Sedation on Peri- and Postprocedural Outcomes in Renal Sympathetic Denervation: A Single-Center Retrospective Study

Source: ClinicalTrials.gov · Last updated 15 Oct 2026

Brief summary (registry, in English)

This retrospective, single-center study investigates the effects of two different sedation regimens-dexmedetomidine versus fentanyl-propofol-on clinical outcomes in patients undergoing catheter-based renal sympathetic denervation for resistant hypertension. The study focuses on peri-procedural safety, recovery, and overall tolerability of sedation approaches in this interventional setting.

Status (registry)
Completed
Study type
Observational
Enrollment
142 (actual)
First submitted
7 Dec 2025
Start date
30 Dec 2024
Primary completion date
30 Jun 2025
Lead sponsor
Ebru Girgin Dinc
NCT number
NCT07293273

What you commit to

  • Study type: Observational
  • Participants enrolled: 142
  • From 30 Dec 2024 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Age \<18

Other

  • Pregnant women

Who the study is looking for

  • Age 18-80 years
  • Underwent renal sympathetic denervation for resistant essential hypertension (2023-2024)
  • Both male and female

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kosuyolu Heart Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.